CRMD Q1 2026 Earnings Strong EPS Surprise Amidst Limited Revenue Visibility CACI Q1 2026 Earnings EPS Beats Estimates Stock Gains 23 Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues HOPE Q1 2026 Earnings Modest EPS Beat as Bank Navigates Margin Pressure THRY Q1 2026 Earnings Significant EPS Surprise Drives Positive Stock Reaction CHRW Q1 2026 Earnings EPS Surpasses Estimates Amid Mixed Market Signals